http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_229bd915bfb0d18ee11dee8244ce07a3
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Miller |
| name | William R Miller William R. Miller |
| given-name | William R William R. |
| organization-name | Center for Infectious Diseases, Houston Methodist Research Institute, Houston, TX 77030, USA; Division of Infectious Diseases, Department of Internal Medicine, Houston Methodist Hospital, Houston, TX 77030, USA William R. Miller, Ph.D., is the director of the research division of the Center on Alcoholism, Substance Abuse, and Addictions, and professor of psychology and psychiatry, University of New Mexico, Alburquerque, New Mexico. Center for Antimicrobial Resistance and Microbial Genomics, University of Texas Health Science Center at Houston, McGovern Medical School, Houston, Texas, USA. Division of Infectious Diseases, University of Texas Health Science Center at Houston, McGovern Medical School, Houston, Texas, USA. William R. Miller, Ph.D., is Regents' Professor of Psychology and Psychiatry and Melanie E. Bennett, Ph.D., is a visiting assistant professor in the Department of Psychology and the Center on Alcoholism, Substance Abuse, and Addictions (CASAA), University of New Mexico, Albuquerque, New Mexico. Authors' Affiliations: 1Division of Clinical Pharmacology, Department of Molecular Pharmacology and Experimental Therapeutics, 2Department of Biochemistry and Molecular Biology, 3Division of Biomedical Statistics and Informatics, Department of Health Sciences Research, and 4Department of Oncology, Mayo Clinic, Rochester, Minnesota; 5Breast Unit, Department of Clinical Oncology, Western General Hospital, University of Edinburgh; 6Breakthrough Research Unit, Edinburgh, United Kingdom; and 7M.D. Anderson Cancer Center Oncology, Houston, Texas University of Edinburgh, Western General Hospital, Scotland, United Kingdom. From the Duke University Comprehensive Cancer Center, Durham, NC; Lombardi Cancer Center, Washington DC; Institut Bergonié, Bordeaux Cedex, France; Instituto Valenciano de Oncologia, Valencia, Spain; Universitaets Frauen-und Poliklinik UKE, Hamburg, Germany; Breast Research Unit, Western General Hospital, Edinburgh, United Kingdom; Novartis Pharma AG, Basel, Switzerland; and Novartis Pharmaceuticals, East Hanover, NJ. Center for Antimicrobial Resistance and Microbial Genomics, University of Texas Health Science Center, Houston, Texas, USA; Division of Infectious Diseases, McGovern Medical School, University of Texas Health Science Center, Houston, Texas, USA Center for Antimicrobial Resistance and Microbial Genomics, UTHealth McGovern Medical School, Houston, TX, USA; Division of Infectious Diseases, UTHealth McGovern Medical School, Houston, TX, USA Breast Research Group, University of Edinburgh, Western General Hospital, Edinburgh, EH4 2XU, UK. Edinburgh Breast Unit, Research Group, Paderewski Building, Western General Hospital From the Breast Research Group, University of Edinburgh, Edinburgh, United Kingdom; Genomics Institute of the Novartis Research Foundation, San Diego, CA; and Novartis Pharma AG, Basel, Switzerland. Center on Alcoholism, Substance Abuse, and Addictions, University of New Mexico, Albuquerque, New Mexico 87131-0001, USA. wrmiller@unm.edu Department of Psychology. University of North Carolina, Wilmington, 601 South College Road, Wilmington, North Carolina 28403-5612, USA. ogler@uncw.edu Alcohol and Drug Abuse Institute, 1107 NE 45th Street, Suite 120, Seattle, Washington 98105-4631 Center for Antimicrobial Resistance and Microbial Genomics, McGovern Medical School, University of Texas Health Science Center, Houston, TX 77030;; Division of Infectious Diseases, McGovern Medical School, University of Texas Health Science Center, Houston, TX 77030; a University of Edinburgh, Edinburgh, UK Department of Psychology and Center on Alcoholism; Substance Abuse and Addictions (CASAA); The University of New Mexico; Albuquerque New Mexico USA Department of Internal Medicine, Division of Infectious Diseases, University of Texas Medical School at Houston, Houston, Texas, USA; Center for Antimicrobial Resistance and Microbial Genomics, University of Texas McGovern Medical School, Houston, Texas, USA From the Siteman Comprehensive Cancer Center, Washington University School of Medicine, St Louis, MO; Duke University Medical Center, Durham, NC; Edinburgh Breast Unit, Edinburgh University, Edinburgh, Scotland; Royal Marsden Hospital, London, United Kingdom; and Novartis Pharma AG, Basel, Switzerland. Center for Antimicrobial Resistance and Microbial Genomics, University of Texas Health Science Center, Houston, TX, USA; Department of Internal Medicine, Division of Infectious Diseases, McGovern Medical School Center on Alcoholism, Substance Abuse, and Addictions, University qf New Mexico, Albuquerque, New Mexico 87131-0001, USA. wrmiller@unm.edu Authors' Affiliations: 1Royal Marsden Hospital; 2Breakthrough Breast Cancer Research Centre, Institute of Cancer Research; 3Cancer Research UK Clinical Trials and Statistics Unit, Section of Clinical Trials, Institute of Cancer Research, London; 4Breast Research Group, University of Edinburgh, Edinburgh, United Kingdom; and 5Department of Biochemistry, University of Otago, Dunedin, New Zealand Center on Alcoholism, Substance Abuse and Addictions (CASAA) of the University of New Mexico; University of New Mexico, Logan Hall, Department of Psychology, Albuquerque, NM 87121-1611; phone: (505) 768-0279. University of New Mexico, Albuquerque The University of New Mexico Center on Alcoholism, Substance Abuse, and Addictions, Department of Psychology, University of New Mexico, Albuquerque, NM 87131, USA. Center on Alcoholism, Substance Abuse and Addictions (CASAA), University of New Mexico, 2650 Yale SE, Albuquerque, New Mexico 87106 Center for Antimicrobial Resistance and Microbial Genomics, Houston, Texas; Division of Infectious Diseases, Department of Internal Medicine, Houston, Texas Center on Alcoholism, Substance Abuse, and Addictions, University of New Mexico, Albuquerque 87106, USA. jtonigan@unm.edu Department of Neurology Galveston TX USA; Center for Addiction Research Galveston TX USA; Mitchell Center for Neurodegenerative Diseases Galveston TX USA Center on Alcoholism, Substance Abuse and Addictions (CASAA) The University of New Mexico Albuquerque NM USA. Center for Antimicrobial Resistance and Microbial Genomics and Gulf Coast Consortium on Antimicrobial Resistance,; Division of Infectious Diseases, Department of Internal Medicine, and RTI International, 3040 Cornwallis Road, Research Triangle Park, North Carolina 27709 Department of Internal Medicine, Division of Infectious Diseases, University of Texas Medical School at Houston, Houston, Texas, USA Center for Antimicrobial Resistance and Microbial Genomics, UTHealth McGovern School of Medicine, Houston, Texas, USA; Division of Infectious Diseases, UTHealth McGovern School of Medicine, Houston, TX, USA Department of Chemistry, University of Michigan, 930 North University Avenue, Ann Arbor, Michigan 48109-1055, United States Department of Psychology, University of New Mexico, Albuquerque, New Mexico 87131-1161;, , Authors' Affiliations: Departments of 1Cancer Biology, 2Medicine, 3Biostatistics, 4Radiology and Radiological Sciences, and 5Pathology; 6Breast Cancer Research Program, Vanderbilt-Ingram Cancer Center; 7Institute of Imaging Sciences, Vanderbilt University, Nashville, Tennessee; 8Breakthrough Breast Cancer Centre, Institute of Cancer Research, and 9Academic Department of Biochemistry, Royal Marsden Hospital, London, UK; 10Novartis Institute for Biomedical Research, Oncology Disease Area, Basel, Switzerland; Departments of 11Breast Medical Oncology and 12Systems Biology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas; 13Breast Research Group, University of Edinburgh, Edinburgh, UK Division of Infectious Diseases, Department of Internal Medicine, University of Texas Medical School at Houston, Houston, Texas, USA Center for Antimicrobial Resistance and Microbial Genomics and Division of Infectious Diseases, University of Texas Health Science Center, McGovern Medical School, Houston, Texas, USA Center for Antimicrobial Resistance and Microbial Genomics, Rice University; Department of Internal Medicine, Division of Infectious Diseases, Rice University Department of Biology and Chemistry, Baker University, Baldwin City, KS, United States of America Center on Alcoholism, Substance Abuse and Addictions (CASAA); The University of New Mexico; Albuquerque NM USA Authors' Affiliations: Departments of 1Cancer Biology, 2Medicine, 3Biostatistics, and 4Breast Cancer Research Program, Vanderbilt-Ingram Comprehensive Cancer Center, Vanderbilt University, Nashville, Tennessee; 5Breakthrough Breast Cancer Centre, Institute of Cancer Research; 6Academic Department of Biochemistry, Royal Marsden Hospital, London, United Kingdom; Departments of 7Breast Medical Oncology and 8Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas; and 9Breast Research Group, University of Edinburgh, Edinburgh, United Kingdom Imperial Cancer Research Fund, Medical Oncology Unit, Western General Hospital, Edinburgh, EH4 2XU, UK Center on Alcoholism, Substance Abuse, and Addictions (CASAA), University of New Mexico, Albuquerque, New Mexico 87106, USA. |
Incoming Links
Total number of triples: 289.